Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
ALDER BIOPHARMACEUTICALS INC (ALDR)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 11/01/2019 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 10/31/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 10/24/2019 |
4
| Campoy Carlos (CFO) has filed a Form 4 on ALDER BIOPHARMACEUTICALS INC|
Txns:
| Disposed/sold 270,000 options to buy
@ $11.5, valued at
$3.1M
|
|
| 10/24/2019 |
4
| STRECK PAUL (Chief Medical Officer) has filed a Form 4 on ALDER BIOPHARMACEUTICALS INC|
Txns:
| Granted 1,390 shares
@ $9.2, valued at
$12.8k
Disposed/sold 1,390 shares
@ $18, valued at
$25k
Disposed/sold 250,000 options to buy
@ $13.41, valued at
$3.4M
|
|
| 10/24/2019 |
4
| Dac Nadia (Chief Commercial Officer) has filed a Form 4 on ALDER BIOPHARMACEUTICALS INC|
Txns:
| Disposed/sold 250,000 options to buy
@ $13.9, valued at
$3.5M
|
|
| 10/24/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/24/2019 |
4
| Lavelle Erin (COO) has filed a Form 4 on ALDER BIOPHARMACEUTICALS INC|
Txns:
| Granted 11,684 shares
@ $0
Unknown transaction of 16,092 shares
@ $18, valued at
$289.7k
Disposed/sold 300,000 options to buy
@ $14.55, valued at
$4.4M
Disposed/sold 150,000 options to buy
@ $14, valued at
$2.1M
|
|
| 10/24/2019 |
4
| Bucher James B (EVP & General Counsel) has filed a Form 4 on ALDER BIOPHARMACEUTICALS INC|
Txns:
| Granted 1,345 shares
@ $9.197, valued at
$12.4k
Granted 904 shares
@ $9.2, valued at
$8.3k
Granted 15,619 shares
@ $0
Unknown transaction of 27,677 shares
@ $18, valued at
$498.2k
Disposed/sold 95,000 options to buy
@ $20.17, valued at
$1.9M
Disposed/sold 50,000 options to buy
@ $20.4, valued at
$1M
Disposed/sold 35,000 options to buy
@ $10.7, valued at
$374.5k
Disposed/sold 70,000 options to buy
@ $13.55, valued at
$948.5k
Disposed/sold 70,000 options to buy
@ $13.24, valued at
$926.8k
Disposed/sold 135,000 options to buy
@ $14, valued at
$1.9M
|
|
| 10/24/2019 |
4
| Hassler Randal (EVP, Pharmaceutical Ops.) has filed a Form 4 on ALDER BIOPHARMACEUTICALS INC|
Txns:
| Granted 14,346 shares
@ $0
Disposed/sold 19,780 shares
@ $18, valued at
$356k
Disposed/sold 80,000 options to buy
@ $11.79, valued at
$943.2k
Disposed/sold 30,000 options to buy
@ $28.23, valued at
$846.9k
Disposed/sold 75,000 options to buy
@ $24.18, valued at
$1.8M
Disposed/sold 60,000 options to buy
@ $20.4, valued at
$1.2M
Disposed/sold 60,000 options to buy
@ $10.7, valued at
$642k
Disposed/sold 80,000 options to buy
@ $13.55, valued at
$1.1M
Disposed/sold 150,000 options to buy
@ $14, valued at
$2.1M
|
|
| 10/24/2019 |
4
| Smith Jeffrey T L (Managing Director) has filed a Form 4 on ALDER BIOPHARMACEUTICALS INC|
Txns:
| Granted 16,230 shares
@ $0
Disposed/sold 21,502 shares
@ $18, valued at
$387k
Disposed/sold 17,271 options to buy
@ $3.465, valued at
$59.8k
Disposed/sold 31,818 options to buy
@ $3.465, valued at
$110.2k
Disposed/sold 13,636 options to buy
@ $6.765, valued at
$92.2k
Disposed/sold 13,636 options to buy
@ $10, valued at
$136.4k
Disposed/sold 35,000 options to buy
@ $16.9, valued at
$591.5k
Disposed/sold 50,000 options to buy
@ $28.23, valued at
$1.4M
Disposed/sold 100,000 options to buy
@ $24.18, valued at
$2.4M
Disposed/sold 85,000 options to buy
@ $20.4, valued at
$1.7M
Disposed/sold 50,000 options to buy
@ $10.7, valued at
$535k
|
|
| 10/24/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/24/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/24/2019 |
4
| Preston Heather (Director) has filed a Form 4 on ALDER BIOPHARMACEUTICALS INC|
Txns:
| Disposed/sold 6,350 options to buy
@ $39.66, valued at
$251.8k
Disposed/sold 15,000 options to buy
@ $29.26, valued at
$438.9k
Disposed/sold 15,000 options to buy
@ $16.9, valued at
$253.5k
|
|
| 10/24/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/24/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/24/2019 |
4
| Carter Paul Rutherford (Director) has filed a Form 4 on ALDER BIOPHARMACEUTICALS INC|
Txns:
| Disposed/sold 30,000 options to buy
@ $31.1, valued at
$933k
Disposed/sold 15,000 options to buy
@ $29.26, valued at
$438.9k
Disposed/sold 15,000 options to buy
@ $16.9, valued at
$253.5k
Disposed/sold 15,000 options to buy
@ $15.5, valued at
$232.5k
Disposed/sold 22,500 options to buy
@ $11.01, valued at
$247.7k
|
|
| 10/24/2019 |
4
| Azelby Robert (President and CEO) has filed a Form 4 on ALDER BIOPHARMACEUTICALS INC|
Txns:
| Disposed/sold 1,000,000 options to buy
@ $16.2, valued at
$16.2M
Disposed/sold 505,000 options to buy
@ $14, valued at
$7.1M
Disposed/sold 15,000 restricted stock units
@ $0
Disposed/sold 150,000 options to buy
@ $16.2, valued at
$2.4M
|
|
| 10/24/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/24/2019 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 10/24/2019 |
SC 13D/A
| H LUNDBECK A S reports a 100% stake in ALDER BIOPHARMACEUTICALS, INC. |
| 10/22/2019 |
POSASR
| Form POSASR - Post-effective Amendment to an automatic shelf registration statement: |
| 10/22/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 10/22/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 10/22/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 10/22/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 10/22/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 10/22/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 10/22/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 10/22/2019 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 10/22/2019 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 10/22/2019 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 10/22/2019 |
8-K
| Quarterly results |
| 10/17/2019 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
|
|
|